Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy

The liver is an essential organ for regulating innate and acquired immunity. We hypothesized that the pre-treatment hepatic function affects the clinical outcome of immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). We analyzed 140 patients with NSCLC who received ICIs. We in...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsukane, Ryosuke, Watanabe, Hiroyuki, Hata, Kojiro, Suetsugu, Kimitaka, Tsuji, Toshikazu, Egashira, Nobuaki, Nakanishi, Yoichi, Okamoto, Isamu, Ieiri, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302741/
https://www.ncbi.nlm.nih.gov/pubmed/34301991
http://dx.doi.org/10.1038/s41598-021-94336-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302741/
https://www.ncbi.nlm.nih.gov/pubmed/34301991
http://dx.doi.org/10.1038/s41598-021-94336-9

Ejemplares similares